Clover Health [CLOV] vs Cigna [CI] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Clover Health Investments Corp. wins in 2 metrics, The Cigna Group wins in 15 metrics, with 1 ties. The Cigna Group appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Clover Health Investments Corp. | The Cigna Group | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -14.09 | 12.61 | The Cigna Group |
| Price-to-Book Ratio | 4.20 | 1.77 | The Cigna Group |
| Debt-to-Equity Ratio | 0.00 | 75.14 | Tie |
| PEG Ratio | -0.09 | -1.32 | Clover Health Investments Corp. |
| EV/EBITDA | -13.96 | 8.02 | The Cigna Group |
| Profit Margin (TTM) | -4.45% | 2.17% | The Cigna Group |
| Operating Margin (TTM) | -10.11% | 3.53% | The Cigna Group |
| EBITDA Margin (TTM) | N/A | 3.53% | N/A |
| Return on Equity | -26.33% | 15.13% | The Cigna Group |
| Return on Assets (TTM) | -9.53% | 4.09% | The Cigna Group |
| Free Cash Flow (TTM) | $-68.98M | $8.39B | The Cigna Group |
| Dividend Yield | N/A | 2.24% | N/A |
| 1-Year Return | 64.24% | -6.11% | Clover Health Investments Corp. |
| Price-to-Sales Ratio (TTM) | 0.68 | 0.27 | The Cigna Group |
| Enterprise Value | $1.19B | $96.61B | The Cigna Group |
| EV/Revenue Ratio | 0.62 | 0.35 | The Cigna Group |
| Gross Profit Margin (TTM) | 15.22% | N/A | N/A |
| Revenue per Share (TTM) | $4 | $1,031 | The Cigna Group |
| Earnings per Share (Diluted) | $-0.17 | $22.18 | The Cigna Group |
| Beta (Stock Volatility) | 2.25 | 0.27 | The Cigna Group |
| Short % of Float | 9.37% | 2.88% | The Cigna Group |
Clover Health Investments Corp. vs The Cigna Group Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Clover Health Investments Corp. | 1.69% | 22.70% | 38.62% | 144.16% | 83.59% | 99.59% |
| The Cigna Group | -1.40% | 1.46% | 3.00% | 9.50% | 6.02% | 5.27% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Clover Health Investments Corp. | 64.24% | 425.56% | -60.71% | -53.63% | -53.63% | -53.63% |
| The Cigna Group | -6.11% | 10.85% | 28.46% | 130.12% | 509.53% | 856.66% |
Performance & Financial Health Analysis: Clover Health Investments Corp. vs The Cigna Group
| Metric | CLOV | CI |
|---|---|---|
| Market Information | ||
| Market Cap | $1.26B | $72.68B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 5,270,275 | 1,414,431 |
| 90 Day Avg. Volume | 5,678,468 | 1,580,340 |
| Last Close | $4.81 | $293.83 |
| 52 Week Range | $1.58 - $5.18 | $239.51 - $338.89 |
| % from 52W High | -7.14% | -13.30% |
| All-Time High | $28.85 (Jun 07, 2021) | $370.83 (Sep 16, 2024) |
| % from All-Time High | -83.33% | -20.76% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.45% | 0.10% |
| Quarterly Earnings Growth | 0.45% | -0.13% |
| Financial Health | ||
| Profit Margin (TTM) | -0.04% | 0.02% |
| Operating Margin (TTM) | -0.10% | 0.04% |
| Return on Equity (TTM) | -0.26% | 0.15% |
| Debt to Equity (MRQ) | 0.00 | 75.14 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.60 | $158.33 |
| Cash per Share (MRQ) | $0.23 | $33.14 |
| Operating Cash Flow (TTM) | $-66,934,000 | $9.60B |
| Levered Free Cash Flow (TTM) | $-35,821,624 | $9.77B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.24% |
| Last 12-Month Dividend | N/A | $6.09 |
Valuation & Enterprise Metrics Analysis: Clover Health Investments Corp. vs The Cigna Group
| Metric | CLOV (Apr 24, 2026) | CI (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -14.09 | 12.61 |
| Forward P/E | 27.78 | 8.37 |
| PEG Ratio | -0.09 | -1.32 |
| Price to Sales (TTM) | 0.68 | 0.27 |
| Price to Book (MRQ) | 4.20 | 1.77 |
| Market Capitalization | ||
| Market Capitalization | $1.26B | $72.68B |
| Enterprise Value | $1.19B | $96.61B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.62 | 0.35 |
| Enterprise to EBITDA | -13.96 | 8.02 |
| Risk & Other Metrics | ||
| Beta | 2.25 | 0.27 |
| Book Value per Share (MRQ) | $0.60 | $158.33 |
Financial Statements Comparison: Clover Health Investments Corp. vs The Cigna Group
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | CLOV (2025) | CI (2025) |
|---|---|---|
| Revenue/Sales | 1.92B | 274.88B |
| Cost of Goods Sold | 1.57B | N/A |
| COGS % of Revenue | 81.5% | 0.0% |
| Gross Profit | 355.90M | N/A |
| Gross Margin | 18.5% | 0.0% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -85.53M | N/A |
| Operating Margin | -4.4% | 0.0% |
| EBITDA | -83.84M | N/A |
| EBITDA Margin | -4.4% | 0.0% |
| Pre-Tax Income | -85.55M | 7.78B |
| Pre-Tax Income % of Revenue | -4.4% | 2.8% |
| Income Tax | N/A | 1.49B |
| Income Tax % of Revenue | 0.0% | 0.5% |
| Net Income (Profit) | -85.55M | 6.29B |
| Profit Margin | -4.4% | 2.3% |
Balance Sheet & Liquidity Metrics
| Metric | CLOV (2025) | CI (2025) |
|---|---|---|
| Cash & Equivalents | 78.30M | 7.68B |
| Total Current Assets | 307.86M | N/A |
| Total Current Assets % of Revenue | 16.0% | 0.0% |
| Total Current Liabilities | 208.82M | N/A |
| Total Current Liabilities % of Revenue | 10.9% | 0.0% |
| Long-Term Debt | N/A | 30.87B |
| Long-Term Debt % of Revenue | 0.0% | 11.2% |
| Total Shareholders Equity | 308.70M | 41.87B |
| Retained Earnings | -2.29B | 47.87B |
| Retained Earnings % of Revenue | -118.9% | 17.4% |
| Property, Plant & Equipment | 113,000 | N/A |
Cash Flow Statement Comparison
| Metric | CLOV (2025) | CI (2025) |
|---|---|---|
| Operating Cash Flow | -57.89M | 5.57B |
| Operating Cash Flow % of Revenue | -3.0% | 2.0% |
| Capital Expenditures | -2.04M | -1.21B |
| Free Cash Flow | -68.98M | 8.39B |
| FCF Margin | -3.6% | 3.1% |
| Debt Repayment | N/A | -6.20B |
| Common Stock Repurchase | -55.20M | -3.62B |
Short Interest & Institutional Ownership Analysis
| Metric | CLOV | CI |
|---|---|---|
| Shares Short | 39.12M | 6.80M |
| Short Ratio | 6.96 | 3.61 |
| Short % of Float | 9.37% | 2.88% |
| Shares Outstanding | 519.04M | 263.46M |
| Float Shares | 406.66M | 262.25M |
| % Held by Insiders | 3.25% | 1.44% |
| % Held by Institutions | 29.71% | 92.21% |
| % Held by Public | 67.04% | 6.35% |
Dividend Analysis & Yield Comparison: Clover Health Investments Corp. vs The Cigna Group
| Metric | CLOV | CI |
|---|---|---|
| Last 12-Month Dividend | N/A | $6.09 |
| Last 12-Month Dividend Yield | N/A | 2.24% |
| 3-Year Avg Annual Dividend | N/A | $5.63 |
| 3-Year Avg Dividend Yield | N/A | 0.47% |
| 3-Year Total Dividends | N/A | $16.89 |
| Ex-Dividend Date | N/A | Mar 05, 2026 |